The occurrence of KRAS mutations differs based on the specific lung cancer type/subtype, being higher in NSCLC than in SCLC, and within NSCLC, KRAS mutations are more frequent in lung AC than SCC (Table 2). This evidence concerns the gene KRAS and non-small cell lung carcinoma.